FDA responds to our concerns about their temporary policy on food labeling changes
The FDA has responded to the group letter submitted by Gluten Free Watchdog and six other patient/consumer advocacy and professional groups outlining our concerns about FDA’s temporary policy on food labeling changes during the COVID-19 pandemic and the impact it may have on the celiac disease community.
The FDA response further clarifies agency position and elaborates on the wording used in their guidance document. Regardless, it appears unlikely that FDA will be amending the current guidance. The agency has however posted a Q&A that focuses on allergens but also mentions gluten. See GUIDANCE.
The yellow highlights in the posted letter were added by Gluten Free Watchdog.